{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:09:48Z","timestamp":1795028988936,"version":"4.10.2"},"reference-count":236,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1038\/s41581-022-00648-y","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T12:04:22Z","timestamp":1669377862000},"page":"102-122","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Nutrient-sensing mTORC1 and AMPK pathways in chronic kidney diseases"],"prefix":"10.1038","volume":"19","author":[{"given":"Christopher","family":"Huynh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewhee","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5920-8496","authenticated-orcid":false,"given":"Jooho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8793-701X","authenticated-orcid":false,"given":"Ayaka","family":"Inoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8882-444X","authenticated-orcid":false,"given":"Ken","family":"Inoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,24]]},"reference":[{"key":"648_CR1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.cmet.2020.01.015","volume":"31","author":"A Gonzalez","year":"2020","unstructured":"Gonzalez, A., Hall, M. N., Lin, S. C. & Hardie, D. G. AMPK and TOR: the Yin and Yang of cellular nutrient sensing and growth control. Cell Metab. 31, 472\u2013492 (2020).","journal-title":"Cell Metab."},{"key":"648_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu, G. Y. & Sabatini, D. M. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol. 21, 183\u2013203 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"648_CR3","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1016\/j.molcel.2021.08.015","volume":"81","author":"E Trefts","year":"2021","unstructured":"Trefts, E. & Shaw, R. J. AMPK: restoring metabolic homeostasis over space and time. Mol. Cell 81, 3677\u20133690 (2021).","journal-title":"Mol. Cell"},{"key":"648_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.cmet.2012.05.010","volume":"16","author":"Y Dagon","year":"2012","unstructured":"Dagon, Y. et al. p70S6 Kinase phosphorylates AMPK on serine 491 to mediate Leptin\u2019s effect on food intake. Cell Metab. 16, 104\u2013112 (2012).","journal-title":"Cell Metab."},{"key":"648_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.cmet.2019.01.018","volume":"29","author":"F Madeo","year":"2019","unstructured":"Madeo, F., Carmona-Gutierrez, D., Hofer, S. J. & Kroemer, G. Caloric restriction mimetics against age-associated disease: targets, mechanisms, and therapeutic potential. Cell Metab. 29, 592\u2013610 (2019).","journal-title":"Cell Metab."},{"key":"648_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","volume":"45","author":"D Carling","year":"2017","unstructured":"Carling, D. AMPK signalling in health and disease. Curr. Opin. Cell Biol. 45, 31\u201337 (2017).","journal-title":"Curr. Opin. Cell Biol."},{"key":"648_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.gde.2012.12.005","volume":"23","author":"M Cornu","year":"2013","unstructured":"Cornu, M., Albert, V. & Hall, M. N. mTOR in aging, metabolism, and cancer. Curr. Opin. Genet. Dev. 23, 53\u201362 (2013).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"648_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.99271","author":"VG Puelles","year":"2019","unstructured":"Puelles, V. G. et al. mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.99271 (2019).","journal-title":"JCI Insight"},{"key":"648_CR9","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1681\/ASN.2016050519","volume":"28","author":"S Zschiedrich","year":"2017","unstructured":"Zschiedrich, S. et al. Targeting mTOR signaling can prevent the progression of FSGS. J. Am. Soc. Nephrol. 28, 2144\u20132157 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR10","doi-asserted-by":"publisher","first-page":"F27","DOI":"10.1152\/ajprenal.00298.2021","volume":"322","author":"NM Pastor-Soler","year":"2022","unstructured":"Pastor-Soler, N. M. et al. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model. Am. J. Physiol. Renal Physiol. 322, F27\u2013F41 (2022).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"648_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1681\/ASN.2004080660","volume":"16","author":"Y Tao","year":"2005","unstructured":"Tao, Y., Kim, J., Schrier, R. W. & Edelstein, C. L. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J. Am. Soc. Nephrol. 16, 46\u201351 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.kint.2021.06.013","volume":"100","author":"RD Perrone","year":"2021","unstructured":"Perrone, R. D. et al.Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD. Kidney Int. 100, 684\u2013696 (2021).","journal-title":"Kidney Int."},{"key":"648_CR13","doi-asserted-by":"publisher","first-page":"721","DOI":"10.7164\/antibiotics.28.721","volume":"28","author":"C Vezina","year":"1975","unstructured":"Vezina, C., Kudelski, A. & Sehgal, S. N. Rapamycin (AY-22,989), a new antifungal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J. Antibiot. 28, 721\u2013726 (1975).","journal-title":"J. Antibiot."},{"key":"648_CR14","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1126\/science.1715094","volume":"253","author":"J Heitman","year":"1991","unstructured":"Heitman, J., Movva, N. R. & Hall, M. N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253, 905\u2013909 (1991).","journal-title":"Science"},{"key":"648_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/0092-8674(93)90144-F","volume":"73","author":"J Kunz","year":"1993","unstructured":"Kunz, J. et al. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73, 585\u2013596 (1993).","journal-title":"Cell"},{"key":"648_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","volume":"78","author":"DM Sabatini","year":"1994","unstructured":"Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P. & Snyder, S. H. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs. Cell 78, 35\u201343 (1994).","journal-title":"Cell"},{"key":"648_CR17","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/369756a0","volume":"369","author":"EJ Brown","year":"1994","unstructured":"Brown, E. J. et al. A mammalian protein targeted by G1-arresting rapamycin-receptor complex. Nature 369, 756\u2013758 (1994).","journal-title":"Nature"},{"key":"648_CR18","doi-asserted-by":"publisher","first-page":"12574","DOI":"10.1073\/pnas.91.26.12574","volume":"91","author":"MI Chiu","year":"1994","unstructured":"Chiu, M. I., Katz, H. & Berlin, V. RAPT1, a mammalian homolog of yeast Tor, interacts with the FKBP12\/rapamycin complex. Proc. Natl Acad. Sci. USA 91, 12574\u201312578 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"648_CR19","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S1097-2765(02)00636-6","volume":"10","author":"R Loewith","year":"2002","unstructured":"Loewith, R. et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457\u2013468 (2002).","journal-title":"Mol. Cell"},{"key":"648_CR20","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/ncb1183","volume":"6","author":"E Jacinto","year":"2004","unstructured":"Jacinto, E. et al. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122\u20131128 (2004).","journal-title":"Nat. Cell Biol."},{"key":"648_CR21","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DD Sarbassov","year":"2004","unstructured":"Sarbassov, D. D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296\u20131302 (2004).","journal-title":"Curr. Biol."},{"key":"648_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0092-8674(02)00808-5","volume":"110","author":"DH Kim","year":"2002","unstructured":"Kim, D. H. et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163\u2013175 (2002).","journal-title":"Cell"},{"key":"648_CR23","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/j.molcel.2015.04.031","volume":"58","author":"C Gaubitz","year":"2015","unstructured":"Gaubitz, C. et al. Molecular basis of the rapamycin insensitivity of target of rapamycin complex 2. Mol. Cell 58, 977\u2013988 (2015).","journal-title":"Mol. Cell"},{"key":"648_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.molcel.2006.03.029","volume":"22","author":"DD Sarbassov","year":"2006","unstructured":"Sarbassov, D. D. et al. Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt\/PKB. Mol. Cell 22, 159\u2013168 (2006).","journal-title":"Mol. Cell"},{"key":"648_CR25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.molcel.2010.05.017","volume":"38","author":"CK Yip","year":"2010","unstructured":"Yip, C. K., Murata, K., Walz, T., Sabatini, D. M. & Kang, S. A. Structure of the human mTOR complex I and its implications for rapamycin inhibition. Mol. Cell 38, 768\u2013774 (2010).","journal-title":"Mol. Cell"},{"key":"648_CR26","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/emboj.2012.32","volume":"31","author":"C Settembre","year":"2012","unstructured":"Settembre, C. et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31, 1095\u20131108 (2012).","journal-title":"EMBO J."},{"key":"648_CR27","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/nm.3313","volume":"19","author":"G Canaud","year":"2013","unstructured":"Canaud, G. et al. AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Nat. Med. 19, 1288\u20131296 (2013).","journal-title":"Nat. Med."},{"key":"648_CR28","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1126\/science.1157535","volume":"320","author":"Y Sancak","year":"2008","unstructured":"Sancak, Y. et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496\u20131501 (2008).","journal-title":"Science"},{"key":"648_CR29","doi-asserted-by":"publisher","first-page":"4622","DOI":"10.1016\/j.molcel.2021.09.001","volume":"81","author":"H Senoo","year":"2021","unstructured":"Senoo, H. et al. KARATE: PKA-induced KRAS4B-RHOA-mTORC2 supercomplex phosphorylates AKT in insulin signaling and glucose homeostasis. Mol. Cell 81, 4622\u20134634 e4628 (2021).","journal-title":"Mol. Cell"},{"key":"648_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","volume":"10","author":"BD Manning","year":"2002","unstructured":"Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J. & Cantley, L. C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/Akt pathway. Mol. Cell 10, 151\u2013162 (2002).","journal-title":"Mol. Cell"},{"key":"648_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K. L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4, 648\u2013657 (2002).","journal-title":"Nat. Cell Biol."},{"key":"648_CR32","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1074\/jbc.AC119.011578","volume":"295","author":"D Meng","year":"2020","unstructured":"Meng, D. et al. Glutamine and asparagine activate mTORC1 independently of Rag GTPases. J. Biol. Chem. 295, 2890\u20132899 (2020).","journal-title":"J. Biol. Chem."},{"key":"648_CR33","doi-asserted-by":"publisher","first-page":"14484","DOI":"10.1074\/jbc.273.23.14484","volume":"273","author":"K Hara","year":"1998","unstructured":"Hara, K. et al. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. J. Biol. Chem. 273, 14484\u201314494 (1998).","journal-title":"J. Biol. Chem."},{"key":"648_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1126\/science.aab2674","volume":"351","author":"RL Wolfson","year":"2016","unstructured":"Wolfson, R. L. et al. Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351, 43\u201348 (2016).","journal-title":"Science"},{"key":"648_CR35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41586-021-03768-w","volume":"596","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. SAR1B senses leucine levels to regulate mTORC1 signalling. Nature 596, 281\u2013284 (2021).","journal-title":"Nature"},{"key":"648_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cell.2016.02.035","volume":"165","author":"L Chantranupong","year":"2016","unstructured":"Chantranupong, L. et al. The CASTOR proteins are arginine sensors for the mTORC1 pathway. Cell 165, 153\u2013164 (2016).","journal-title":"Cell"},{"key":"648_CR37","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1126\/science.1257132","volume":"347","author":"S Wang","year":"2015","unstructured":"Wang, S. et al. Metabolism. Lysosomal amino acid transporter SLC38A9 signals arginine sufficiency to mTORC1. Science 347, 188\u2013194 (2015).","journal-title":"Science"},{"key":"648_CR38","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1126\/science.1232044","volume":"340","author":"L Bar-Peled","year":"2013","unstructured":"Bar-Peled, L. et al. A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 340, 1100\u20131106 (2013).","journal-title":"Science"},{"key":"648_CR39","unstructured":"proteinatlas. SAR1B \u2014 The Human Protein Atlas https:\/\/www.proteinatlas.org\/search\/SAR1B (2021)."},{"key":"648_CR40","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1126\/science.aao3265","volume":"358","author":"X Gu","year":"2017","unstructured":"Gu, X. et al. SAMTOR is an S-adenosylmethionine sensor for the mTORC1 pathway. Science 358, 813\u2013818 (2017).","journal-title":"Science"},{"key":"648_CR41","doi-asserted-by":"publisher","first-page":"9545","DOI":"10.1073\/pnas.1811727115","volume":"115","author":"K Shen","year":"2018","unstructured":"Shen, K. & Sabatini, D. M. Ragulator and SLC38A9 activate the Rag GTPases through noncanonical GEF mechanisms. Proc. Natl Acad. Sci. USA 115, 9545\u20139550 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"648_CR42","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.1207056","volume":"334","author":"R Zoncu","year":"2011","unstructured":"Zoncu, R. et al. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H+-ATPase. Science 334, 678\u2013683 (2011).","journal-title":"Science"},{"key":"648_CR43","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1038\/s41594-020-0490-9","volume":"27","author":"SA Fromm","year":"2020","unstructured":"Fromm, S. A., Lawrence, R. E. & Hurley, J. H. Structural mechanism for amino acid-dependent Rag GTPase nucleotide state switching by SLC38A9. Nat. Struct. Mol. Biol. 27, 1017\u20131023 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"648_CR44","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-020-2444-0","volume":"585","author":"G Napolitano","year":"2020","unstructured":"Napolitano, G. et al. A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dube syndrome. Nature 585, 597\u2013602 (2020).","journal-title":"Nature"},{"key":"648_CR45","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","volume":"47","author":"CC Dibble","year":"2012","unstructured":"Dibble, C. C. et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol. Cell 47, 535\u2013546 (2012).","journal-title":"Mol. Cell"},{"key":"648_CR46","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Li, Y., Xu, T. & Guan, K. L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes. Dev. 17, 1829\u20131834 (2003).","journal-title":"Genes. Dev."},{"key":"648_CR47","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2013.11.049","volume":"156","author":"S Menon","year":"2014","unstructured":"Menon, S. et al. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 156, 771\u2013785 (2014).","journal-title":"Cell"},{"key":"648_CR48","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.cell.2014.01.024","volume":"156","author":"C Demetriades","year":"2014","unstructured":"Demetriades, C., Doumpas, N. & Teleman, A. A. Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2. Cell 156, 786\u2013799 (2014).","journal-title":"Cell"},{"key":"648_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.molcel.2020.10.004","volume":"80","author":"Y Yao","year":"2020","unstructured":"Yao, Y. et al. Amino acids enhance polyubiquitination of Rheb and its binding to mTORC1 by blocking lysosomal ATXN3 deubiquitinase activity. Mol. Cell 80, 437\u2013451 e436 (2020).","journal-title":"Mol. Cell"},{"key":"648_CR50","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1158\/2159-8290.CD-15-0460","volume":"5","author":"P Liu","year":"2015","unstructured":"Liu, P. et al. PtdIns(3,4,5)P3-dependent activation of the mTORC2 kinase complex. Cancer Discov. 5, 1194\u20131209 (2015).","journal-title":"Cancer Discov."},{"key":"648_CR51","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.devcel.2016.08.001","volume":"38","author":"S Krishna","year":"2016","unstructured":"Krishna, S. et al. PIKfyve regulates vacuole maturation and nutrient recovery following engulfment. Dev. Cell 38, 536\u2013547 (2016).","journal-title":"Dev. Cell"},{"key":"648_CR52","doi-asserted-by":"publisher","first-page":"ar26","DOI":"10.1091\/mbc.E21-06-0309","volume":"33","author":"J Hasegawa","year":"2022","unstructured":"Hasegawa, J. et al. PP2A-dependent TFEB activation is blocked by PIKfyve-induced mTORC1 activity. Mol. Biol. Cell 33, ar26 (2022).","journal-title":"Mol. Biol. Cell"},{"key":"648_CR53","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.molcel.2021.04.019","volume":"81","author":"K Fitzian","year":"2021","unstructured":"Fitzian, K. et al. TSC1 binding to lysosomal PIPs is required for TSC complex translocation and mTORC1 regulation. Mol. Cell 81, 2705\u20132721 e2708 (2021).","journal-title":"Mol. Cell"},{"key":"648_CR54","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1126\/science.aag1417","volume":"355","author":"BM Castellano","year":"2017","unstructured":"Castellano, B. M. et al. Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex. Science 355, 1306\u20131311 (2017).","journal-title":"Science"},{"key":"648_CR55","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/s41556-019-0391-5","volume":"21","author":"CY Lim","year":"2019","unstructured":"Lim, C. Y. et al. ER-lysosome contacts enable cholesterol sensing by mTORC1 and drive aberrant growth signalling in Niemann-Pick type C. Nat. Cell Biol. 21, 1206\u20131218 (2019).","journal-title":"Nat. Cell Biol."},{"key":"648_CR56","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1126\/science.abg6621","volume":"377","author":"HR Shin","year":"2022","unstructured":"Shin, H. R. et al. Lysosomal GPCR-like protein LYCHOS signals cholesterol sufficiency to mTORC1. Science 377, 1290\u20131298 (2022).","journal-title":"Science"},{"key":"648_CR57","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.devcel.2020.11.016","volume":"56","author":"OB Davis","year":"2021","unstructured":"Davis, O. B. et al. NPC1-mTORC1 signaling couples cholesterol sensing to organelle homeostasis and is a targetable pathway in Niemann-Pick type C. Dev. Cell 56, 260\u2013276 e267 (2021).","journal-title":"Dev. Cell"},{"key":"648_CR58","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1126\/science.1066015","volume":"294","author":"Y Fang","year":"2001","unstructured":"Fang, Y., Vilella-Bach, M., Bachmann, R., Flanigan, A. & Chen, J. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294, 1942\u20131945 (2001).","journal-title":"Science"},{"key":"648_CR59","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.bbalip.2009.04.001","volume":"1791","author":"EE Kooijman","year":"2009","unstructured":"Kooijman, E. E. & Burger, K. N. Biophysics and function of phosphatidic acid: a molecular perspective. Biochim. Biophys. Acta 1791, 881\u2013888 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"648_CR60","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.bbalip.2009.02.009","volume":"1791","author":"DA Foster","year":"2009","unstructured":"Foster, D. A. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells. Biochim. Biophys. Acta 1791, 949\u2013955 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"648_CR61","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.yexcr.2012.03.011","volume":"318","author":"C Huang","year":"2012","unstructured":"Huang, C., Bruggeman, L. A., Hydo, L. M. & Miller, R. T. Shear stress induces cell apoptosis via a c-Src-phospholipase D-mTOR signaling pathway in cultured podocytes. Exp. Cell Res. 318, 1075\u20131085 (2012).","journal-title":"Exp. Cell Res."},{"key":"648_CR62","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1074\/jbc.RA119.010892","volume":"295","author":"MA Frias","year":"2020","unstructured":"Frias, M. A. et al. Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids. J. Biol. Chem. 295, 263\u2013274 (2020).","journal-title":"J. Biol. Chem."},{"key":"648_CR63","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s42255-020-0250-5","volume":"2","author":"JM Orozco","year":"2020","unstructured":"Orozco, J. M. et al. Dihydroxyacetone phosphate signals glucose availability to mTORC1. Nat. Metab. 2, 893\u2013901 (2020).","journal-title":"Nat. Metab."},{"key":"648_CR64","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Zhu, T. & Guan, K.-L. TSC2 Mediates cellular energy response to control cell growth and survival. Cell 115, 577\u2013590 (2003).","journal-title":"Cell"},{"key":"648_CR65","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn, D. M. et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214\u2013226 (2008).","journal-title":"Mol. Cell"},{"key":"648_CR66","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1113\/JP278246","volume":"597","author":"L Tappy","year":"2019","unstructured":"Tappy, L. & Rosset, R. Health outcomes of a high fructose intake: the importance of physical activity. J. Physiol. 597, 3561\u20133571 (2019).","journal-title":"J. Physiol."},{"key":"648_CR67","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1681\/ASN.2019101015","volume":"31","author":"T Nakagawa","year":"2020","unstructured":"Nakagawa, T. et al. Fructose production and metabolism in the kidney. J. Am. Soc. Nephrol. 31, 898\u2013906 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR68","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1016\/j.cell.2022.04.013","volume":"185","author":"S Battaglioni","year":"2022","unstructured":"Battaglioni, S., Benjamin, D., Walchli, M., Maier, T. & Hall, M. N. mTOR substrate phosphorylation in growth control. Cell 185, 1814\u20131836 (2022).","journal-title":"Cell"},{"key":"648_CR69","doi-asserted-by":"publisher","first-page":"6026","DOI":"10.1074\/jbc.M115.689646","volume":"291","author":"C Puente","year":"2016","unstructured":"Puente, C., Hendrickson, R. C. & Jiang, X. Nutrient-regulated phosphorylation of ATG13 inhibits starvation-induced autophagy. J. Biol. Chem. 291, 6026\u20136035 (2016).","journal-title":"J. Biol. Chem."},{"key":"648_CR70","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1091\/mbc.e08-12-1248","volume":"20","author":"N Hosokawa","year":"2009","unstructured":"Hosokawa, N. et al. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell 20, 1981\u20131991 (2009).","journal-title":"Mol. Biol. Cell"},{"key":"648_CR71","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.molcel.2014.11.013","volume":"57","author":"YM Kim","year":"2015","unstructured":"Kim, Y. M. et al. mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and endosome maturation. Mol. Cell 57, 207\u2013218 (2015).","journal-title":"Mol. Cell"},{"key":"648_CR72","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nature18943","volume":"536","author":"A Rousseau","year":"2016","unstructured":"Rousseau, A. & Bertolotti, A. An evolutionarily conserved pathway controls proteasome homeostasis. Nature 536, 184\u2013189 (2016).","journal-title":"Nature"},{"key":"648_CR73","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/nature13492","volume":"513","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. Coordinated regulation of protein synthesis and degradation by mTORC1. Nature 513, 440\u2013443 (2014).","journal-title":"Nature"},{"key":"648_CR74","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1038\/emboj.2011.257","volume":"30","author":"S Pena-Llopis","year":"2011","unstructured":"Pena-Llopis, S. et al. Regulation of TFEB and V-ATPases by mTORC1. EMBO J. 30, 3242\u20133258 (2011).","journal-title":"EMBO J."},{"key":"648_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24499-6","volume":"12","author":"N Alesi","year":"2021","unstructured":"Alesi, N. et al. TSC2 regulates lysosome biogenesis via a non-canonical RAGC and TFEB-dependent mechanism. Nat. Commun. 12, 4245 (2021).","journal-title":"Nat. Commun."},{"key":"648_CR76","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1126\/science.1205407","volume":"332","author":"M Narita","year":"2011","unstructured":"Narita, M. et al. Spatial coupling of mTOR and autophagy augments secretory phenotypes. Science 332, 966\u2013970 (2011).","journal-title":"Science"},{"key":"648_CR77","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1080\/15548627.2019.1705007","volume":"16","author":"T Bork","year":"2020","unstructured":"Bork, T. et al. Podocytes maintain high basal levels of autophagy independent of mtor signaling. Autophagy 16, 1932\u20131948 (2020).","journal-title":"Autophagy"},{"key":"648_CR78","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/S0960-9822(03)00249-5","volume":"13","author":"ER Hudson","year":"2003","unstructured":"Hudson, E. R. et al. A novel domain in AMP-activated protein kinase causes glycogen storage bodies similar to those seen in hereditary cardiac arrhythmias. Curr. Biol. 13, 861\u2013866 (2003).","journal-title":"Curr. Biol."},{"key":"648_CR79","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0960-9822(03)00292-6","volume":"13","author":"G Polekhina","year":"2003","unstructured":"Polekhina, G. et al. AMPK beta subunit targets metabolic stress sensing to glycogen. Curr. Biol. 13, 867\u2013871 (2003).","journal-title":"Curr. Biol."},{"key":"648_CR80","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nature06161","volume":"449","author":"B Xiao","year":"2007","unstructured":"Xiao, B. et al. Structural basis for AMP binding to mammalian AMP-activated protein kinase. Nature 449, 496\u2013500 (2007).","journal-title":"Nature"},{"key":"648_CR81","doi-asserted-by":"publisher","first-page":"27879","DOI":"10.1074\/jbc.271.44.27879","volume":"271","author":"SA Hawley","year":"1996","unstructured":"Hawley, S. A. et al. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271, 27879\u201327887 (1996).","journal-title":"J. Biol. Chem."},{"key":"648_CR82","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.chembiol.2014.03.006","volume":"21","author":"JW Scott","year":"2014","unstructured":"Scott, J. W. et al. Small molecule drug A-769662 and AMP synergistically activate naive AMPK independent of upstream kinase signaling. Chem. Biol. 21, 619\u2013627 (2014).","journal-title":"Chem. Biol."},{"key":"648_CR83","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmet.2005.05.009","volume":"2","author":"SA Hawley","year":"2005","unstructured":"Hawley, S. A. et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9\u201319 (2005).","journal-title":"Cell Metab."},{"key":"648_CR84","doi-asserted-by":"publisher","first-page":"25336","DOI":"10.1074\/jbc.M604399200","volume":"281","author":"M Momcilovic","year":"2006","unstructured":"Momcilovic, M., Hong, S.-P. & Carlson, M. Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro*. J. Biol. Chem. 281, 25336\u201325343 (2006).","journal-title":"J. Biol. Chem."},{"key":"648_CR85","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.cub.2003.10.031","volume":"13","author":"A Woods","year":"2003","unstructured":"Woods, A. et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr. Biol. 13, 2004\u20132008 (2003).","journal-title":"Curr. Biol."},{"key":"648_CR86","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature09932","volume":"472","author":"B Xiao","year":"2011","unstructured":"Xiao, B. et al. Structure of mammalian AMPK and its regulation by ADP. Nature 472, 230\u2013233 (2011).","journal-title":"Nature"},{"key":"648_CR87","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1126\/science.1200094","volume":"332","author":"JS Oakhill","year":"2011","unstructured":"Oakhill, J. S. et al. AMPK is a direct adenylate charge-regulated protein kinase. Science 332, 1433\u20131435 (2011).","journal-title":"Science"},{"key":"648_CR88","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1016\/j.molcel.2021.08.025","volume":"81","author":"C-C Hsu","year":"2021","unstructured":"Hsu, C.-C. et al. Inositol serves as a natural inhibitor of mitochondrial fission by directly targeting AMPK. Mol. Cell 81, 3803\u20133819.e3807 (2021).","journal-title":"Mol. Cell"},{"key":"648_CR89","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature23275","volume":"548","author":"CS Zhang","year":"2017","unstructured":"Zhang, C. S. et al. Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK. Nature 548, 112\u2013116 (2017).","journal-title":"Nature"},{"key":"648_CR90","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.cmet.2019.05.018","volume":"30","author":"M Li","year":"2019","unstructured":"Li, M. et al. Transient receptor potential V channels are essential for glucose sensing by aldolase and AMPK. Cell Metab. 30, 508\u2013524.e512 (2019).","journal-title":"Cell Metab."},{"key":"648_CR91","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.cmet.2013.09.005","volume":"18","author":"YL Zhang","year":"2013","unstructured":"Zhang, Y. L. et al. AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation. Cell Metab. 18, 546\u2013555 (2013).","journal-title":"Cell Metab."},{"key":"648_CR92","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.cmet.2014.06.014","volume":"20","author":"CS Zhang","year":"2014","unstructured":"Zhang, C. S. et al. The lysosomal v-ATPase-Ragulator complex is a common activator for AMPK and mTORC1, acting as a switch between catabolism and anabolism. Cell Metab. 20, 526\u2013540 (2014).","journal-title":"Cell Metab."},{"key":"648_CR93","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","volume":"27","author":"SC Lin","year":"2018","unstructured":"Lin, S. C. & Hardie, D. G. AMPK: sensing glucose as well as cellular energy status. Cell Metab. 27, 299\u2013313 (2018).","journal-title":"Cell Metab."},{"key":"648_CR94","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1074\/jbc.M506850200","volume":"281","author":"S Horman","year":"2006","unstructured":"Horman, S. et al. Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase \u03b1-subunits in heart via hierarchical phosphorylation of Ser485\/491*. J. Biol. Chem. 281, 5335\u20135340 (2006).","journal-title":"J. Biol. Chem."},{"key":"648_CR95","doi-asserted-by":"publisher","first-page":"696","DOI":"10.4161\/auto.7.7.15451","volume":"7","author":"AS Loffler","year":"2011","unstructured":"Loffler, A. S. et al. Ulk1-mediated phosphorylation of AMPK constitutes a negative regulatory feedback loop. Autophagy 7, 696\u2013706 (2011).","journal-title":"Autophagy"},{"key":"648_CR96","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1042\/BJ20131344","volume":"459","author":"SA Hawley","year":"2014","unstructured":"Hawley, S. A. et al. Phosphorylation by Akt within the ST loop of AMPK-alpha1 down-regulates its activation in tumour cells. Biochem. J. 459, 275\u2013287 (2014).","journal-title":"Biochem. J."},{"key":"648_CR97","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.molcel.2013.03.022","volume":"50","author":"T Suzuki","year":"2013","unstructured":"Suzuki, T. et al. Inhibition of AMPK catabolic action by GSK3. Mol. Cell 50, 407\u2013419 (2013).","journal-title":"Mol. Cell"},{"key":"648_CR98","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s42255-019-0157-1","volume":"2","author":"NXY Ling","year":"2020","unstructured":"Ling, N. X. Y. et al. mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress. Nat. Metab. 2, 41\u201349 (2020).","journal-title":"Nat. Metab."},{"key":"648_CR99","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1016\/j.febslet.2014.07.025","volume":"588","author":"FR Auciello","year":"2014","unstructured":"Auciello, F. R., Ross, F. A., Ikematsu, N. & Hardie, D. G. Oxidative stress activates AMPK in cultured cells primarily by increasing cellular AMP and\/or ADP. FEBS Lett. 588, 3361\u20133366 (2014).","journal-title":"FEBS Lett."},{"key":"648_CR100","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7053","volume":"6","author":"PC Hart","year":"2015","unstructured":"Hart, P. C. et al. MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer. Nat. Commun. 6, 6053 (2015).","journal-title":"Nat. Commun."},{"key":"648_CR101","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.freeradbiomed.2009.02.019","volume":"46","author":"BM Emerling","year":"2009","unstructured":"Emerling, B. M. et al. Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP\/ATP ratio. Free. Radic. Biol. Med. 46, 1386\u20131391 (2009).","journal-title":"Free. Radic. Biol. Med."},{"key":"648_CR102","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.cmet.2013.12.013","volume":"19","author":"D Shao","year":"2014","unstructured":"Shao, D. et al. A redox-dependent mechanism for regulation of AMPK activation by Thioredoxin1 during energy starvation. Cell Metab. 19, 232\u2013245 (2014).","journal-title":"Cell Metab."},{"key":"648_CR103","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2016.81","volume":"48","author":"SM Jeon","year":"2016","unstructured":"Jeon, S. M. Regulation and function of AMPK in physiology and diseases. Exp. Mol. Med. 48, e245 (2016).","journal-title":"Exp. Mol. Med."},{"key":"648_CR104","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/nm.3372","volume":"19","author":"MD Fullerton","year":"2013","unstructured":"Fullerton, M. D. et al. Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. Nat. Med. 19, 1649\u20131654 (2013).","journal-title":"Nat. Med."},{"key":"648_CR105","doi-asserted-by":"publisher","first-page":"7282","DOI":"10.1073\/pnas.0602205103","volume":"103","author":"MJ Wolfgang","year":"2006","unstructured":"Wolfgang, M. J. et al. The brain-specific carnitine palmitoyltransferase-1c regulates energy homeostasis. Proc. Natl Acad. Sci. USA 103, 7282\u20137287 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"648_CR106","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/415339a","volume":"415","author":"Y Minokoshi","year":"2002","unstructured":"Minokoshi, Y. et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339\u2013343 (2002).","journal-title":"Nature"},{"key":"648_CR107","doi-asserted-by":"publisher","first-page":"9261","DOI":"10.1073\/pnas.90.20.9261","volume":"90","author":"R Sato","year":"1993","unstructured":"Sato, R., Goldstein, J. L. & Brown, M. S. Replacement of serine-871 of hamster 3-hydroxy-3-methylglutaryl-CoA reductase prevents phosphorylation by AMP-activated kinase and blocks inhibition of sterol synthesis induced by ATP depletion. Proc. Natl Acad. Sci. Usa. 90, 9261\u20139265 (1993).","journal-title":"Proc. Natl Acad. Sci. Usa."},{"key":"648_CR108","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.cmet.2011.03.009","volume":"13","author":"Y Li","year":"2011","unstructured":"Li, Y. et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13, 376\u2013388 (2011).","journal-title":"Cell Metab."},{"key":"648_CR109","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2011.05.002","volume":"13","author":"M Ahmadian","year":"2011","unstructured":"Ahmadian, M. et al. Desnutrin\/ATGL is regulated by AMPK and is required for a Brown Adipose Phenotype. Cell Metab. 13, 739\u2013748 (2011).","journal-title":"Cell Metab."},{"key":"648_CR110","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.molcel.2013.01.035","volume":"49","author":"N Wu","year":"2013","unstructured":"Wu, N. et al. AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol. Cell 49, 1167\u20131175 (2013).","journal-title":"Mol. Cell"},{"key":"648_CR111","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/S0960-9822(00)00742-9","volume":"10","author":"AS Marsin","year":"2000","unstructured":"Marsin, A. S. et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr. Biol. 10, 1247\u20131255 (2000).","journal-title":"Curr. Biol."},{"key":"648_CR112","doi-asserted-by":"publisher","first-page":"30778","DOI":"10.1074\/jbc.M205213200","volume":"277","author":"A-S Marsin","year":"2002","unstructured":"Marsin, A.-S., Bouzin, C., Bertrand, L. & Hue, L. The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase *. J. Biol. Chem. 277, 30778\u201330783 (2002).","journal-title":"J. Biol. Chem."},{"key":"648_CR113","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nature03967","volume":"437","author":"SH Koo","year":"2005","unstructured":"Koo, S. H. et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109\u20131111 (2005).","journal-title":"Nature"},{"key":"648_CR114","doi-asserted-by":"publisher","first-page":"12220","DOI":"10.1074\/jbc.M309773200","volume":"279","author":"GJ Browne","year":"2004","unstructured":"Browne, G. J., Finn, S. G. & Proud, C. G. Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J. Biol. Chem. 279, 12220\u201312231 (2004).","journal-title":"J. Biol. Chem."},{"key":"648_CR115","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.molcel.2010.05.007","volume":"38","author":"AY Choo","year":"2010","unstructured":"Choo, A. Y. et al. Glucose addiction of TSC null cells is caused by failed mTORC1-dependent balancing of metabolic demand with supply. Mol. Cell 38, 487\u2013499 (2010).","journal-title":"Mol. Cell"},{"key":"648_CR116","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41574-021-00551-9","volume":"17","author":"M Kitada","year":"2021","unstructured":"Kitada, M. & Koya, D. Autophagy in metabolic disease and ageing. Nat. Rev. Endocrinol. 17, 647\u2013661 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"648_CR117","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim, J., Kundu, M., Viollet, B. & Guan, K.-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol. 13, 132\u2013141 (2011).","journal-title":"Nat. Cell Biol."},{"key":"648_CR118","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1126\/science.1196371","volume":"331","author":"DF Egan","year":"2011","unstructured":"Egan, D. F. et al. Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331, 456\u2013461 (2011).","journal-title":"Science"},{"key":"648_CR119","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2012.12.016","volume":"152","author":"J Kim","year":"2013","unstructured":"Kim, J. et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 152, 290\u2013303 (2013).","journal-title":"Cell"},{"key":"648_CR120","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1080\/15548627.2021.1898748","volume":"17","author":"M Paquette","year":"2021","unstructured":"Paquette, M. et al. AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3. Autophagy 17, 3957\u20133975 (2021).","journal-title":"Autophagy"},{"key":"648_CR121","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/ncb2757","volume":"15","author":"RC Russell","year":"2013","unstructured":"Russell, R. C. et al. ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat. Cell Biol. 15, 741\u2013750 (2013).","journal-title":"Nat. Cell Biol."},{"key":"648_CR122","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.molcel.2015.05.031","volume":"59","author":"DF Egan","year":"2015","unstructured":"Egan, D. F. et al. Small molecule inhibition of the autophagy kinase ULK1 and identification of ULK1 substrates. Mol. Cell 59, 285\u2013297 (2015).","journal-title":"Mol. Cell"},{"key":"648_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20071427","volume":"410","author":"JM Backer","year":"2008","unstructured":"Backer, J. M. The regulation and function of Class III PI3Ks: novel roles for Vps34. Biochem. J. 410, 1\u201317 (2008).","journal-title":"Biochem. J."},{"key":"648_CR124","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1042\/BCJ20160170","volume":"473","author":"JM Backer","year":"2016","unstructured":"Backer, J. M. The intricate regulation and complex functions of the Class III phosphoinositide 3-kinase Vps34. Biochem. J. 473, 2251\u20132271 (2016).","journal-title":"Biochem. J."},{"key":"648_CR125","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201798804","author":"R Puertollano","year":"2018","unstructured":"Puertollano, R., Ferguson, S. M., Brugarolas, J. & Ballabio, A. The complex relationship between TFEB transcription factor phosphorylation and subcellular localization. EMBO J. https:\/\/doi.org\/10.15252\/embj.201798804 (2018).","journal-title":"EMBO J."},{"key":"648_CR126","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.molcel.2017.04.026","volume":"66","author":"X Li","year":"2017","unstructured":"Li, X. et al. Nucleus-translocated ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy. Mol. Cell 66, 684\u2013697 e689 (2017).","journal-title":"Mol. Cell"},{"key":"648_CR127","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature18014","volume":"534","author":"H-JR Shin","year":"2016","unstructured":"Shin, H.-J. R. et al. AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy. Nature 534, 553 (2016). +.","journal-title":"Nature"},{"key":"648_CR128","doi-asserted-by":"publisher","first-page":"30107","DOI":"10.1074\/jbc.M705325200","volume":"282","author":"EL Greer","year":"2007","unstructured":"Greer, E. L. et al. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem. 282, 30107\u201330119 (2007).","journal-title":"J. Biol. Chem."},{"key":"648_CR129","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41581-020-00369-0","volume":"17","author":"C Tang","year":"2021","unstructured":"Tang, C. et al. Mitochondrial quality control in kidney injury and repair. Nat. Rev. Nephrol. 17, 299\u2013318 (2021).","journal-title":"Nat. Rev. Nephrol."},{"key":"648_CR130","doi-asserted-by":"publisher","first-page":"15983","DOI":"10.1073\/pnas.252625599","volume":"99","author":"H Zong","year":"2002","unstructured":"Zong, H. et al. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation. Proc. Natl Acad. Sci. USA 99, 15983\u201315987 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"648_CR131","doi-asserted-by":"publisher","first-page":"12017","DOI":"10.1073\/pnas.0705070104","volume":"104","author":"S J\u00e4ger","year":"2007","unstructured":"J\u00e4ger, S., Handschin, C., St.-Pierre, J. & Spiegelman, B. M. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1\u03b1. Proc. Natl Acad. Sci. USA 104, 12017\u201312022 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"648_CR132","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0092-8674(00)80611-X","volume":"98","author":"Z Wu","year":"1999","unstructured":"Wu, Z. et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115\u2013124 (1999).","journal-title":"Cell"},{"key":"648_CR133","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/ng0398-231","volume":"18","author":"NG Larsson","year":"1998","unstructured":"Larsson, N. G. et al. Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat. Genet. 18, 231\u2013236 (1998).","journal-title":"Nat. Genet."},{"key":"648_CR134","doi-asserted-by":"publisher","first-page":"E1340","DOI":"10.1152\/ajpendo.2001.281.6.E1340","volume":"281","author":"R Bergeron","year":"2001","unstructured":"Bergeron, R. et al. Chronic activation of AMP kinase results in NRF-1 activation and mitochondrial biogenesis. Am. J. Physiol. Endocrinol. Metab. 281, E1340\u2013E1346 (2001).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"648_CR135","doi-asserted-by":"publisher","first-page":"35724","DOI":"10.1074\/jbc.M805078200","volume":"283","author":"PM Garcia-Roves","year":"2008","unstructured":"Garcia-Roves, P. M., Osler, M. E., Holmstr\u00f6m, M. H. & Zierath, J. R. Gain-of-function R225Q mutation in AMP-activated protein kinase gamma3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle. J. Biol. Chem. 283, 35724\u201335734 (2008).","journal-title":"J. Biol. Chem."},{"key":"648_CR136","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.tcb.2019.08.003","volume":"29","author":"H-G Sprenger","year":"2019","unstructured":"Sprenger, H.-G. & Langer, T. The good and the bad of mitochondrial breakups. Trends Cell Biol. 29, 888\u2013900 (2019).","journal-title":"Trends Cell Biol."},{"key":"648_CR137","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tem.2015.12.001","volume":"27","author":"T Wai","year":"2016","unstructured":"Wai, T. & Langer, T. Mitochondrial dynamics and metabolic regulation. Trends Endocrinol. Metab. 27, 105\u2013117 (2016).","journal-title":"Trends Endocrinol. Metab."},{"key":"648_CR138","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1126\/science.aab4138","volume":"351","author":"EQ Toyama","year":"2016","unstructured":"Toyama, E. Q. et al. Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science 351, 275\u2013281 (2016).","journal-title":"Science"},{"key":"648_CR139","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1083\/jcb.201007152","volume":"191","author":"H Otera","year":"2010","unstructured":"Otera, H. et al. Mff is an essential factor for mitochondrial recruitment of Drp1 during mitochondrial fission in mammalian cells. J. Cell Biol. 191, 1141\u20131158 (2010).","journal-title":"J. Cell Biol."},{"key":"648_CR140","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08004-0","volume":"10","author":"Z Chen","year":"2019","unstructured":"Chen, Z. et al. Global phosphoproteomic analysis reveals ARMC10 as an AMPK substrate that regulates mitochondrial dynamics. Nat. Commun. 10, 104 (2019).","journal-title":"Nat. Commun."},{"key":"648_CR141","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.cmet.2015.09.001","volume":"22","author":"NJ Hoffman","year":"2015","unstructured":"Hoffman, N. J. et al. Global phosphoproteomic analysis of human skeletal muscle reveals a network of exercise-regulated kinases and AMPK substrates. Cell Metab. 22, 922\u2013935 (2015).","journal-title":"Cell Metab."},{"key":"648_CR142","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/ncb2220","volume":"13","author":"LC Gomes","year":"2011","unstructured":"Gomes, L. C., Di Benedetto, G. & Scorrano, L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat. Cell Biol. 13, 589 (2011).","journal-title":"Nat. Cell Biol."},{"key":"648_CR143","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1126\/science.aay0542","volume":"367","author":"P Zhao","year":"2020","unstructured":"Zhao, P. et al. An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis. Science 367, 652\u2013660 (2020).","journal-title":"Science"},{"key":"648_CR144","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079313","volume":"8","author":"N Godefroy","year":"2013","unstructured":"Godefroy, N., Foveau, B., Albrecht, S., Goodyer, C. G. & LeBlanc, A. C. Expression and activation of caspase-6 in human fetal and adult tissues. PLoS One 8, e79313 (2013).","journal-title":"PLoS One"},{"key":"648_CR145","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1172\/JCI44774","volume":"121","author":"M Godel","year":"2011","unstructured":"Godel, M. et al. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. J. Clin. Invest. 121, 2197\u20132209 (2011).","journal-title":"J. Clin. Invest."},{"key":"648_CR146","doi-asserted-by":"publisher","first-page":"4506","DOI":"10.1172\/JCI128503","volume":"129","author":"JA Torres","year":"2019","unstructured":"Torres, J. A. et al. Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease. J. Clin. Invest. 129, 4506\u20134522 (2019).","journal-title":"J. Clin. Invest."},{"key":"648_CR147","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1681\/ASN.2011040340","volume":"23","author":"Z Novalic","year":"2012","unstructured":"Novalic, Z. et al. Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease. J. Am. Soc. Nephrol. 23, 842\u2013853 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR148","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1172\/JCI44771","volume":"121","author":"K Inoki","year":"2011","unstructured":"Inoki, K. et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J. Clin. Invest. 121, 2181\u20132196 (2011).","journal-title":"J. Clin. Invest."},{"key":"648_CR149","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/ndt\/gfn744","volume":"24","author":"DC Fischer","year":"2009","unstructured":"Fischer, D. C. et al. Activation of the AKT\/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD). Nephrol. Dial. Transpl. 24, 1819\u20131827 (2009).","journal-title":"Nephrol. Dial. Transpl."},{"key":"648_CR150","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1093\/hmg\/ddu208","volume":"23","author":"K Ravichandran","year":"2014","unstructured":"Ravichandran, K. et al. An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2. Hum. Mol. Genet. 23, 4919\u20134931 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"648_CR151","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/ncb3363","volume":"18","author":"S Kim","year":"2016","unstructured":"Kim, S. et al. The polycystin complex mediates Wnt\/Ca2+ signalling. Nat. Cell Biol. 18, 752\u2013764 (2016).","journal-title":"Nat. Cell Biol."},{"key":"648_CR152","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1681\/ASN.2007070770","volume":"19","author":"I Kim","year":"2008","unstructured":"Kim, I. et al. Fibrocystin\/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function. J. Am. Soc. Nephrol. 19, 455\u2013468 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR153","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1002\/hep.29652","volume":"67","author":"E Kaffe","year":"2018","unstructured":"Kaffe, E. et al. beta-Catenin and interleukin-1beta-dependent chemokine (C-X-C motif) ligand 10 production drives progression of disease in a mouse model of congenital hepatic fibrosis. Hepatology 67, 1903\u20131919 (2018).","journal-title":"Hepatology"},{"key":"648_CR154","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/ng1294-328","volume":"8","author":"PT Brook-Carter","year":"1994","unstructured":"Brook-Carter, P. T. et al. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease \u2014 a contiguous gene syndrome. Nat. Genet. 8, 328\u2013332 (1994).","journal-title":"Nat. Genet."},{"key":"648_CR155","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1073\/pnas.0509694103","volume":"103","author":"JM Shillingford","year":"2006","unstructured":"Shillingford, J. M. et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc. Natl Acad. Sci. USA 103, 5466\u20135471 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"648_CR156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009239","volume":"5","author":"R Dere","year":"2010","unstructured":"Dere, R., Wilson, P. D., Sandford, R. N. & Walker, C. L. Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR. PLoS One 5, e9239 (2010).","journal-title":"PLoS One"},{"key":"648_CR157","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/ki.2010.250","volume":"78","author":"I Zafar","year":"2010","unstructured":"Zafar, I., Ravichandran, K., Belibi, F. A., Doctor, R. B. & Edelstein, C. L. Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease. Kidney Int. 78, 754\u2013761 (2010).","journal-title":"Kidney Int."},{"key":"648_CR158","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/ndt\/gfi181","volume":"21","author":"PR Wahl","year":"2006","unstructured":"Wahl, P. R. et al. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol. Dial. Transpl. 21, 598\u2013604 (2006).","journal-title":"Nephrol. Dial. Transpl."},{"key":"648_CR159","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G Walz","year":"2010","unstructured":"Walz, G. et al. Everolimus in patients with autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 830\u2013840 (2010).","journal-title":"N. Engl. J. Med."},{"key":"648_CR160","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra, A. L. et al. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 363, 820\u2013829 (2010).","journal-title":"N. Engl. J. Med."},{"key":"648_CR161","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1681\/ASN.2012111080","volume":"24","author":"K Yamahara","year":"2013","unstructured":"Yamahara, K. et al. Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions. J. Am. Soc. Nephrol. 24, 1769\u20131781 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR162","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/j.celrep.2019.04.012","volume":"27","author":"PT Brinkkoetter","year":"2019","unstructured":"Brinkkoetter, P. T. et al. Anaerobic glycolysis maintains the glomerular filtration barrier independent of mitochondrial metabolism and dynamics. Cell Rep. 27, 1551\u20131566.e1555 (2019).","journal-title":"Cell Rep."},{"key":"648_CR163","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","volume":"21","author":"HM Kang","year":"2015","unstructured":"Kang, H. M. et al. Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development. Nat. Med. 21, 37\u201346 (2015).","journal-title":"Nat. Med."},{"key":"648_CR164","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.86976","volume":"1","author":"KM Sas","year":"2016","unstructured":"Sas, K. M. et al. Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications. JCI Insight 1, e86976 (2016).","journal-title":"JCI Insight"},{"key":"648_CR165","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.1016\/j.apsb.2021.05.013","volume":"11","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Spatial-resolved metabolomics reveals tissue-specific metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging. Acta Pharm. Sin. B 11, 3665\u20133677 (2021).","journal-title":"Acta Pharm. Sin. B"},{"key":"648_CR166","doi-asserted-by":"publisher","first-page":"861","DOI":"10.4161\/cc.10.6.14930","volume":"10","author":"GA Soliman","year":"2011","unstructured":"Soliman, G. A. The integral role of mTOR in lipid metabolism. Cell Cycle 10, 861\u2013862 (2011).","journal-title":"Cell Cycle"},{"key":"648_CR167","doi-asserted-by":"publisher","first-page":"107954","DOI":"10.1016\/j.celrep.2020.107954","volume":"32","author":"A Kogot-Levin","year":"2020","unstructured":"Kogot-Levin, A. et al. Proximal tubule mTORC1 is a central player in the pathophysiology of diabetic nephropathy and its correction by SGLT2 inhibitors. Cell Rep. 32, 107954 (2020).","journal-title":"Cell Rep."},{"key":"648_CR168","doi-asserted-by":"publisher","first-page":"E2817","DOI":"10.1073\/pnas.1402352111","volume":"111","author":"F Grahammer","year":"2014","unstructured":"Grahammer, F. et al. mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress. Proc. Natl Acad. Sci. USA 111, E2817\u2013E2826 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"648_CR169","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrneph.2016.108","volume":"12","author":"D Fantus","year":"2016","unstructured":"Fantus, D., Rogers, N. M., Grahammer, F., Huber, T. B. & Thomson, A. W. Roles of mTOR complexes in the kidney: implications for renal disease and transplantation. Nat. Rev. Nephrol. 12, 587\u2013609 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"648_CR170","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1681\/ASN.2012030271","volume":"23","author":"A Fukuda","year":"2012","unstructured":"Fukuda, A. et al. Growth-dependent podocyte failure causes glomerulosclerosis. J. Am. Soc. Nephrol. 23, 1351\u20131363 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR171","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1681\/ASN.2017020174","volume":"28","author":"R Nishizono","year":"2017","unstructured":"Nishizono, R. et al. FSGS as an adaptive response to growth-induced podocyte stress. J. Am. Soc. Nephrol. 28, 2931\u20132945 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR172","doi-asserted-by":"publisher","first-page":"701","DOI":"10.2337\/db13-0752","volume":"63","author":"J Guzman","year":"2014","unstructured":"Guzman, J. et al. Podocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathy. Diabetes 63, 701\u2013714 (2014).","journal-title":"Diabetes"},{"key":"648_CR173","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI39492","volume":"120","author":"B Hartleben","year":"2010","unstructured":"Hartleben, B. et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J. Clin. Invest. 120, 1084\u20131096 (2010).","journal-title":"J. Clin. Invest."},{"key":"648_CR174","doi-asserted-by":"publisher","first-page":"F585","DOI":"10.1152\/ajprenal.00186.2009","volume":"297","author":"JK Chen","year":"2009","unstructured":"Chen, J. K., Chen, J., Thomas, G., Kozma, S. C. & Harris, R. C. S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy. Am. J. Physiol. Renal Physiol. 297, F585\u2013F593 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"648_CR175","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16978-z","volume":"11","author":"M Bonucci","year":"2020","unstructured":"Bonucci, M. et al. mTOR and S6K1 drive polycystic kidney by the control of Afadin-dependent oriented cell division. Nat. Commun. 11, 3200 (2020).","journal-title":"Nat. Commun."},{"key":"648_CR176","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/MNH.0000000000000349","volume":"26","author":"R Rajani","year":"2017","unstructured":"Rajani, R., Pastor-Soler, N. M. & Hallows, K. R. Role of AMP-activated protein kinase in kidney tubular transport, metabolism, and disease. Curr. Opin. Nephrol. Hypertens. 26, 375\u2013383 (2017).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"648_CR177","doi-asserted-by":"publisher","first-page":"F1067","DOI":"10.1152\/ajprenal.00005.2010","volume":"298","author":"KR Hallows","year":"2010","unstructured":"Hallows, K. R., Mount, P. F., Pastor-Soler, N. M. & Power, D. A. Role of the energy sensor AMP-activated protein kinase in renal physiology and disease. Am. J. Physiol. Renal Physiol. 298, F1067\u2013F1077 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"648_CR178","unstructured":"proteinatlas. Tissue Cell Type \u2014 PRKAA1 \u2014 The Human Protein Atlas https:\/\/www.proteinatlas.org\/ENSG00000132356-PRKAA1\/tissue+cell+type\/kidney (2021)."},{"key":"648_CR179","doi-asserted-by":"publisher","first-page":"F578","DOI":"10.1152\/ajprenal.00190.2004","volume":"288","author":"S Fraser","year":"2005","unstructured":"Fraser, S. et al. Regulation of the energy sensor AMP-activated protein kinase in the kidney by dietary salt intake and osmolality. Am. J. Physiol. Renal Physiol. 288, F578\u2013F586 (2005).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"648_CR180","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1681\/ASN.2011010026","volume":"22","author":"A-E Decl\u00e8ves","year":"2011","unstructured":"Decl\u00e8ves, A.-E., Mathew, A. V., Cunard, R. & Sharma, K. AMPK mediates the initiation of kidney disease induced by a high-fat diet. J. Am. Soc. Nephrol. 22, 1846\u20131855 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR181","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2337\/db10-0386","volume":"60","author":"M Kitada","year":"2011","unstructured":"Kitada, M., Kume, S., Imaizumi, N. & Koya, D. Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK\/SIRT1-independent pathway. Diabetes 60, 634\u2013643 (2011).","journal-title":"Diabetes"},{"key":"648_CR182","doi-asserted-by":"publisher","first-page":"F617","DOI":"10.1152\/ajprenal.00278.2006","volume":"292","author":"M-J Lee","year":"2007","unstructured":"Lee, M.-J. et al. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am. J. Physiol. Renal Physiol. 292, F617\u2013F627 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"648_CR183","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev-physiol-052521-121841","volume":"84","author":"MS Balzer","year":"2022","unstructured":"Balzer, M. S., Rohacs, T. & Susztak, K. How many cell types are in the kidney and what do they do? Annu. Rev. Physiol. 84, 507\u2013531 (2022).","journal-title":"Annu. Rev. Physiol."},{"key":"648_CR184","first-page":"1645","volume":"118","author":"K Sharma","year":"2008","unstructured":"Sharma, K. et al. Adiponectin regulates albuminuria and podocyte function in mice. J. Clin. Invest. 118, 1645\u20131656 (2008).","journal-title":"J. Clin. Invest."},{"key":"648_CR185","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1681\/ASN.2007010089","volume":"18","author":"S Kume","year":"2007","unstructured":"Kume, S. et al. Role of altered renal lipid metabolism in the development of renal injury induced by a high-fat diet. J. Am. Soc. Nephrol. 18, 2715\u20132723 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR186","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1681\/ASN.2014121181","volume":"27","author":"SH Han","year":"2016","unstructured":"Han, S. H. et al. Deletion of Lkb1 in renal tubular epithelial cells leads to CKD by altering metabolism. J. Am. Soc. Nephrol. 27, 439\u2013453 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR187","doi-asserted-by":"publisher","first-page":"F352","DOI":"10.1152\/ajprenal.00169.2016","volume":"312","author":"Y Lazo-Fernandez","year":"2017","unstructured":"Lazo-Fernandez, Y. et al. Kidney-specific genetic deletion of both AMPK alpha-subunits causes salt and water wasting. Am. J. Physiol. Renal Physiol. 312, F352\u2013F365 (2017).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"648_CR188","doi-asserted-by":"publisher","first-page":"23428","DOI":"10.1074\/jbc.M116.738591","volume":"291","author":"X Yang","year":"2016","unstructured":"Yang, X. et al. Physiological expression of AMPKgamma2RG mutation causes Wolff-Parkinson-white syndrome and induces kidney injury in mice. J. Biol. Chem. 291, 23428\u201323439 (2016).","journal-title":"J. Biol. Chem."},{"key":"648_CR189","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1042\/CS20210821","volume":"135","author":"L Wilson","year":"2021","unstructured":"Wilson, L. et al. Chronic activation of AMP-activated protein kinase leads to early-onset polycystic kidney phenotype. Clin. Sci. 135, 2393\u20132408 (2021).","journal-title":"Clin. Sci."},{"key":"648_CR190","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1681\/ASN.2015030231","volume":"27","author":"M Chiaravalli","year":"2016","unstructured":"Chiaravalli, M. et al. 2-Deoxy-d-Glucose ameliorates PKD progression. J. Am. Soc. Nephrol. 27, 1958\u20131969 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR191","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nm.3092","volume":"19","author":"I Rowe","year":"2013","unstructured":"Rowe, I. et al. Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy. Nat. Med. 19, 488\u2013493 (2013).","journal-title":"Nat. Med."},{"key":"648_CR192","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.17047","author":"A Calcagni","year":"2016","unstructured":"Calcagni, A. et al. Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling. Elife https:\/\/doi.org\/10.7554\/eLife.17047 (2016).","journal-title":"Elife"},{"key":"648_CR193","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41581-020-0309-2","volume":"16","author":"C Tang","year":"2020","unstructured":"Tang, C., Livingston, M. J., Liu, Z. & Dong, Z. Autophagy in kidney homeostasis and disease. Nat. Rev. Nephrol. 16, 489\u2013508 (2020).","journal-title":"Nat. Rev. Nephrol."},{"key":"648_CR194","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1146\/annurev-physiol-021119-034658","volume":"82","author":"ME Choi","year":"2020","unstructured":"Choi, M. E. Autophagy in kidney disease. Annu. Rev. Physiol. 82, 297\u2013322 (2020).","journal-title":"Annu. Rev. Physiol."},{"key":"648_CR195","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1681\/ASN.2010070705","volume":"22","author":"T Kimura","year":"2011","unstructured":"Kimura, T. et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J. Am. Soc. Nephrol. 22, 902\u2013913 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR196","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1681\/ASN.2018100983","volume":"30","author":"S Sakai","year":"2019","unstructured":"Sakai, S. et al. Proximal tubule autophagy differs in type 1 and 2 diabetes. J. Am. Soc. Nephrol. 30, 929\u2013945 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR197","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1523-1755.2005.00433.x","volume":"68","author":"K Nagai","year":"2005","unstructured":"Nagai, K. et al. Gas6 induces Akt\/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney Int. 68, 552\u2013561 (2005).","journal-title":"Kidney Int."},{"key":"648_CR198","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bbrc.2005.12.012","volume":"340","author":"M Sakaguchi","year":"2006","unstructured":"Sakaguchi, M. et al. Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice. Biochem. Biophys. Res. Commun. 340, 296\u2013301 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"648_CR199","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1681\/ASN.2005050549","volume":"17","author":"N Lloberas","year":"2006","unstructured":"Lloberas, N. et al. Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats. J. Am. Soc. Nephrol. 17, 1395\u20131404 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR200","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1681\/ASN.2015010032","volume":"27","author":"Y Yao","year":"2016","unstructured":"Yao, Y. et al. Role of ragulator in the regulation of mechanistic target of rapamycin signaling in podocytes and glomerular function. J. Am. Soc. Nephrol. 27, 3653\u20133665 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR201","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.bbrc.2009.04.136","volume":"384","author":"H Mori","year":"2009","unstructured":"Mori, H. et al. The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential. Biochem. Biophys. Res. Commun. 384, 471\u2013475 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"648_CR202","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cmet.2020.06.020","volume":"32","author":"I Tomita","year":"2020","unstructured":"Tomita, I. et al. SGLT2 Inhibition mediates protection from diabetic kidney disease by promoting ketone body-induced mTORC1 inhibition. Cell Metab. 32, 404\u2013419 e406 (2020).","journal-title":"Cell Metab."},{"key":"648_CR203","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1093\/ndt\/gfp367","volume":"24","author":"J Torras","year":"2009","unstructured":"Torras, J. et al. Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage. Nephrol. Dial. Transpl. 24, 3632\u20133640 (2009).","journal-title":"Nephrol. Dial. Transpl."},{"key":"648_CR204","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2215\/CJN.03751106","volume":"2","author":"E Letavernier","year":"2007","unstructured":"Letavernier, E. et al. High sirolimus levels may induce focal segmental glomerulosclerosis de novo. Clin. J. Am. Soc. Nephrol. 2, 326\u2013333 (2007).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"648_CR205","doi-asserted-by":"publisher","first-page":"114498","DOI":"10.1016\/j.ejmech.2022.114498","volume":"238","author":"P Oleksak","year":"2022","unstructured":"Oleksak, P. et al. Contemporary mTOR inhibitor scaffolds to diseases breakdown: a patent review (2015-2021). Eur. J. Med. Chem. 238, 114498 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"648_CR206","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1681\/ASN.2005070742","volume":"17","author":"A Eid","year":"2006","unstructured":"Eid, A. et al. Intrinsic gluconeogenesis is enhanced in renal proximal tubules of Zucker diabetic fatty rats. J. Am. Soc. Nephrol. 17, 398\u2013405 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"648_CR207","doi-asserted-by":"publisher","first-page":"382","DOI":"10.2337\/diacare.24.2.382","volume":"24","author":"JE Gerich","year":"2001","unstructured":"Gerich, J. E., Meyer, C., Woerle, H. J. & Stumvoll, M. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care 24, 382\u2013391 (2001).","journal-title":"Diabetes Care"},{"key":"648_CR208","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1042\/BJ20140620","volume":"462","author":"HR Bridges","year":"2014","unstructured":"Bridges, H. R., Jones, A. J., Pollak, M. N. & Hirst, J. Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. Biochem. J. 462, 475\u2013487 (2014).","journal-title":"Biochem. J."},{"key":"648_CR209","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.taap.2008.08.013","volume":"233","author":"JA Dykens","year":"2008","unstructured":"Dykens, J. A. et al. Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. Toxicol. Appl. Pharmacol. 233, 203\u2013210 (2008).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"648_CR210","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3109\/00498259409043220","volume":"24","author":"C Wilcock","year":"1994","unstructured":"Wilcock, C. & Bailey, C. J. Accumulation of metformin by tissues of the normal and diabetic mouse. Xenobiotica 24, 49\u201357 (1994).","journal-title":"Xenobiotica"},{"key":"648_CR211","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","volume":"42","author":"TE LaMoia","year":"2021","unstructured":"LaMoia, T. E. & Shulman, G. I. Cellular and molecular mechanisms of metformin action. Endocr. Rev. 42, 77\u201396 (2021).","journal-title":"Endocr. Rev."},{"key":"648_CR212","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04431-8","author":"T Ma","year":"2022","unstructured":"Ma, T. et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature https:\/\/doi.org\/10.1038\/s41586-022-04431-8 (2022).","journal-title":"Nature"},{"key":"648_CR213","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1016\/j.celrep.2019.09.070","volume":"29","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Metformin improves mitochondrial respiratory activity through activation of AMPK. Cell Rep. 29, 1511\u20131523 e1515 (2019).","journal-title":"Cell Rep."},{"key":"648_CR214","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cmet.2016.12.009","volume":"25","author":"JJ Howell","year":"2017","unstructured":"Howell, J. J. et al. Metformin inhibits hepatic mTORC1 signaling via dose-dependent mechanisms involving AMPK and the TSC complex. Cell Metab. 25, 463\u2013471 (2017).","journal-title":"Cell Metab."},{"key":"648_CR215","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1016\/j.celrep.2019.10.117","volume":"29","author":"BD Stein","year":"2019","unstructured":"Stein, B. D. et al. Quantitative in vivo proteomics of metformin response in liver reveals AMPK-dependent and -independent signaling networks. Cell Rep. 29, 3331\u20133348 e3337 (2019).","journal-title":"Cell Rep."},{"key":"648_CR216","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2122287119","volume":"119","author":"TE LaMoia","year":"2022","unstructured":"LaMoia, T. E. et al. Metformin, phenformin, and galegine inhibit complex IV activity and reduce glycerol-derived gluconeogenesis. Proc. Natl Acad. Sci. USA 119, e2122287119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"648_CR217","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmet.2016.09.003","volume":"24","author":"CS Zhang","year":"2016","unstructured":"Zhang, C. S. et al. Metformin activates AMPK through the lysosomal pathway. Cell Metab. 24, 521\u2013522 (2016).","journal-title":"Cell Metab."},{"key":"648_CR218","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1073\/pnas.1011498108","volume":"108","author":"V Takiar","year":"2011","unstructured":"Takiar, V. et al. Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc. Natl Acad. Sci. USA 108, 2462\u20132467 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"648_CR219","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1126\/science.aah5582","volume":"357","author":"RW Myers","year":"2017","unstructured":"Myers, R. W. et al. Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophy. Science 357, 507\u2013511 (2017).","journal-title":"Science"},{"key":"648_CR220","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ebiom.2018.04.009","volume":"31","author":"RM Esquejo","year":"2018","unstructured":"Esquejo, R. M. et al. Activation of liver AMPK with PF-06409577 corrects NAFLD and lowers cholesterol in rodent and primate preclinical models. EBioMedicine 31, 122\u2013132 (2018).","journal-title":"EBioMedicine"},{"key":"648_CR221","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cmet.2006.05.005","volume":"3","author":"B Cool","year":"2006","unstructured":"Cool, B. et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 3, 403\u2013416 (2006).","journal-title":"Cell Metab."},{"key":"648_CR222","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1124\/jpet.119.258244","volume":"371","author":"X Zhou","year":"2019","unstructured":"Zhou, X. et al. PAN-AMPK activation improves renal function in a rat model of progressive diabetic nephropathy. J. Pharmacol. Exp. Ther. 371, 45\u201355 (2019).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"648_CR223","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1124\/jpet.116.237925","volume":"361","author":"CT Salatto","year":"2017","unstructured":"Salatto, C. T. et al. Selective activation of AMPK \u03b21-containing isoforms improves kidney function in a rat model of diabetic nephropathy. J. Pharmacol. Exp. Ther. 361, 303\u2013311 (2017).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"648_CR224","doi-asserted-by":"publisher","first-page":"F731","DOI":"10.1152\/ajprenal.00541.2015","volume":"311","author":"W Lieberthal","year":"2016","unstructured":"Lieberthal, W., Tang, M., Lusco, M., Abate, M. & Levine, J. S. Preconditioning mice with activators of AMPK ameliorates ischemic acute kidney injury in vivo. Am. J. Physiol. Renal Physiol. 311, F731\u2013F739 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"648_CR225","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1007\/s00125-018-4656-5","volume":"61","author":"C Ghezzi","year":"2018","unstructured":"Ghezzi, C., Loo, D. D. F. & Wright, E. M. Physiology of renal glucose handling via SGLT1, SGLT2 and GLUT2. Diabetologia 61, 2087\u20132097 (2018).","journal-title":"Diabetologia"},{"key":"648_CR226","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrneph.2016.170","volume":"13","author":"RA DeFronzo","year":"2017","unstructured":"DeFronzo, R. A., Norton, L. & Abdul-Ghani, M. Renal, metabolic and cardiovascular considerations of SGLT2 inhibition. Nat. Rev. Nephrol. 13, 11\u201326 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"648_CR227","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1152\/ajpregu.00357.2011","volume":"302","author":"SC Thomson","year":"2012","unstructured":"Thomson, S. C. et al. Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302, R75\u2013R83 (2012).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"648_CR228","doi-asserted-by":"publisher","first-page":"F194","DOI":"10.1152\/ajprenal.00520.2013","volume":"306","author":"V Vallon","year":"2014","unstructured":"Vallon, V. et al. SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice. Am. J. Physiol. Renal Physiol. 306, F194\u2013F204 (2014).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"648_CR229","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1161\/CIRCULATIONAHA.117.029529","volume":"136","author":"K Striepe","year":"2017","unstructured":"Striepe, K. et al. Effects of the selective sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function and central hemodynamics in patients with type 2 diabetes mellitus. Circulation 136, 1167\u20131169 (2017).","journal-title":"Circulation"},{"key":"648_CR230","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","volume":"61","author":"S Verma","year":"2018","unstructured":"Verma, S. & McMurray, J. J. V. SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review. Diabetologia 61, 2108\u20132117 (2018).","journal-title":"Diabetologia"},{"key":"648_CR231","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/dom.12881","volume":"19","author":"H Al Jobori","year":"2017","unstructured":"Al Jobori, H. et al. Determinants of the increase in ketone concentration during SGLT2 inhibition in NGT, IFG and T2DM patients. Diabetes Obes. Metab. 19, 809\u2013813 (2017).","journal-title":"Diabetes Obes. Metab."},{"key":"648_CR232","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.molcel.2016.03.036","volume":"62","author":"Z Xie","year":"2016","unstructured":"Xie, Z. et al. Metabolic regulation of gene expression by histone lysine beta-hydroxybutyrylation. Mol. Cell 62, 194\u2013206 (2016).","journal-title":"Mol. Cell"},{"key":"648_CR233","doi-asserted-by":"publisher","first-page":"109487","DOI":"10.1016\/j.celrep.2021.109487","volume":"36","author":"KB Koronowski","year":"2021","unstructured":"Koronowski, K. B. et al. Ketogenesis impact on liver metabolism revealed by proteomics of lysine beta-hydroxybutyrylation. Cell Rep. 36, 109487 (2021).","journal-title":"Cell Rep."},{"key":"648_CR234","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061457","author":"J Xu","year":"2021","unstructured":"Xu, J., Kitada, M., Ogura, Y., Liu, H. & Koya, D. Dapagliflozin restores impaired autophagy and suppresses inflammation in high glucose-treated HK-2 cells. Cells https:\/\/doi.org\/10.3390\/cells10061457 (2021).","journal-title":"Cells"},{"key":"648_CR235","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/dom.13961","volume":"22","author":"M Packer","year":"2020","unstructured":"Packer, M. Interplay of adenosine monophosphate-activated protein kinase\/sirtuin-1 activation and sodium influx inhibition mediates the renal benefits of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes: a novel conceptual framework. Diabetes Obes. Metab. 22, 734\u2013742 (2020).","journal-title":"Diabetes Obes. Metab."},{"key":"648_CR236","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.2337\/db16-0058","volume":"65","author":"SA Hawley","year":"2016","unstructured":"Hawley, S. A. et al. The Na+\/glucose cotransporter inhibitor canagliflozin activates AMPK by inhibiting mitochondrial function and increasing cellular AMP levels. Diabetes 65, 2784\u20132794 (2016).","journal-title":"Diabetes"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00648-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00648-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00648-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T05:28:32Z","timestamp":1674278912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-022-00648-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,24]]},"references-count":236,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["648"],"URL":"https:\/\/doi.org\/10.1038\/s41581-022-00648-y","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,24]]},"assertion":[{"value":"20 October 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}